Dimension Therapeutics, Inc
DMTX
DMTX was delisted on the 6th of November, 2017.
52 hedge funds and large institutions have $129M invested in Dimension Therapeutics, Inc in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 3 closing their positions.
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
200% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 7
30% more funds holding
Funds holding: 40 → 52 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less capital invested
Capital invested by funds: $169M → $129M (-$40.3M)
Top Buyers
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$12.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.65M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.31M |
| 4 |
Goldman Sachs
New York
|
+$736K |
| 5 |
SIM
Spark Investment Management
New York
|
+$466K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| $3.04K | +$3.86K | +507 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $1K | +$1.14K | +150 | New |
|
53
Jennison Associates
New York
| – | -$5.83M | -745,801 | Closed |
|
|
FCMI
54
Foresite Capital Management III
Larkspur,
California
| – | -$770K | -98,297 | Closed |
|
55
Wells Fargo
San Francisco,
California
| – | -$8K | -1,020 | Closed |
|
DMTX Hedge Fund Activity: Q2 2016 in Review
52 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q2 2016, worth a combined $129M — down 24% from $169M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new DMTX positions and 3 closed out — a net gain of 12 holders — while 21 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity International, opening a new position worth an estimated $12.9M. The largest seller was Fidelity Investments, cutting an estimated $16M.
- 52 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q2 2016, up from 40 in Q1 2016.
- Funds reported $129M of Dimension Therapeutics, Inc stock for Q2 2016, down 24% quarter-over-quarter.
- 15 funds opened new Dimension Therapeutics, Inc positions in Q2 2016 and 3 closed out, a net change of +12 holders.
- The largest Dimension Therapeutics, Inc buyer in Q2 2016 was Fidelity International, an estimated $12.9M added.
- The largest Dimension Therapeutics, Inc seller in Q2 2016 was Fidelity Investments, an estimated $16M sold.
Based on aggregated 13F filings for Q2 2016.